Though the government is committed to making India Tuberculosis-free by 2025, the ‘END TB’ programme initiated by Prime Minister Narendra Modi in March...
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group...